Viewing Study NCT01307618


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2026-02-20 @ 6:25 PM
Study NCT ID: NCT01307618
Status: TERMINATED
Last Update Posted: 2016-10-24
First Post: 2011-03-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma
Sponsor:
Organization: